For more information, visit http://www.bio-rad.com/CheckoutPrecis... For a primary antibody to be selected as a PrecisionAb Antibody, it must be highly specific, highly sensitive, and pass a rigorous validation process that includes consistent performance from batch to batch. Out of throusands of primary antibodies screened, only a few are admitted into the elite PrecisionAb Antibody category. Try PrecisionAb Antibodies and see how you can generate reproducible data without wasting time and resources on optimization. PrecisionAb Validated Western Blotting Antibodies offer researchers • High specificity and sensitivity – selected for low nonspecific binding, correct target molecular weight, and the strongest signal on a western blot • Reproducible results – stringent QC requirements ensure consistent lot-to-lot performance • Trial size for every antibody (2 applications) - conveniently evaluate western blot performance • Confidence in your data – positive control lysate provided for each antibody; validation protocol included We Are Bio-Rad. Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges. Connect with Bio-Rad Antibodies Online: Website: https://www.bio-rad-antibodies.com/ LinkedIn: https://www.linkedin.com/showcase/bio... Facebook: https://www.facebook.com/BioRadAntibo... Twitter: https://twitter.com/BioRadAbs Pinterest: https://www.pinterest.com/BioRadAbs/ Instagram: @BioRadLabs Snapchat: @BioRadLabs
How Does an Antibody Become a PrecisionAb™ Antibody?
Video Nov 24, 2017
In this Front Row lecture, Assistant Professor Michael Erb will share his research applying chemical tools to study how chromatin, a molecular machine that plays a key role in transcription, becomes disrupted in cancer. He will discuss his research developing small molecule drugs targeting these genetic malfunctions.WATCH NOW